GlobalData Plc
  • Press Release

    Asia-Pacific pedicle screw-based dynamic stabilization systems market to surpass $19 million by 2023

The pedicle screw-based dynamic stabilization systems space across the seven major Asia-Pacific (APAC) markets of Australia, China, India, Japan, New Zealand, South Korea and Taiwan, is set to rise from $12.5 million in 2016 to $19.2 million by 2023, representing a compound annual growth rate (CAGR) of 6.3%, according to GlobalData, a recognized leader in providing business information and analytics.

The company’s latest report states that key drivers of this growth include the rising prevalence of degenerative spinal conditions due to the increasing aging population and the system’s advantages over traditional spinal fusion procedures, including motion preservation.

Jennifer Ryan, Healthcare Analyst for GlobalData, explains: “Future adoption of pedicle screw-based dynamic stabilization systems is highly dependent on the procurement of clinical efficacy data demonstrating support for device utilization.

“This is because, despite generating great enthusiasm upon their introduction to the market, pedicle screw-based dynamic stabilization systems have attracted concern over the long-term clinical efficacy of these devices, with reports emerging of devices loosening and failing. As such, spinal fusion remains the gold standard treatment for patients with degenerative spinal disorders.”

In terms of key players, the pedicle screw-based dynamic stabilization systems market is fairly consolidated, with the majority of players consisting of well-established orthopedic and spine companies. Zimmer Biomet’s Dynesys system is the principal player worldwide, and systems from Globus Medical and Paradigm Spine are also highly utilized.

Ryan continues: “Lingering questions about the clinical effectiveness of these pedicle screw-based dynamic systems is a major setback threatening the continued adoption of currently marketed devices. GlobalData believes the use of clinical trials focused on efficacy will be an important factor in the future of pedicle-screw based dynamic stabilization systems’ adoption and reimbursement.”

In terms of individual countries, China represented the largest portion of the market in 2016, holding just over 40% of the regional revenue, and is expected to maintain this dominance throughout the forecast period. India is expected to be the fastest-growing market through 2023, at a CAGR of 7.9% while the slowest growth will be observed will be observed in New Zealand at a CAGR of 3.7%.

– Information based on GlobalData’s report: MediPoint: Pedicle Screw-Based Dynamic Stabilization Systems – APAC Analysis and Market Forecasts.

Related Intelligence

Want more Insight like this?

Our interactive subscription platform has the most comprehensive data and analysis in your industry.

Request a Demo

Related Consulting

How can we help your business?

Our consultants are skilled in every specialist market niche to deliver solutions specifically designed for your individual requirements.

Request a Callback

    Press Release Healthcare

    Late-stage CKD-induced comorbidity therapeutics market to reach $10.5bn by 2026

    Sales for chronic kidney disease (CKD)-induced hyperparathyroidism (HPT), hyperphosphatemia (HP), and hyperkalemia (HK) therapeutics were estimated to be $4.2bn across the seven major markets (7MM*) in 2016. This is expected to grow to $10.5bn in 2026, at a Compound Annual Growth Rate (CAGR) of 9.5%, according to GlobalData, a leading data and analytics company.

    Press Release Healthcare

    Majority of oncology clinical trials in China failed to meet enrolment targets

    The majority of oncology clinical trials in China that had a start date between 1 January 2012 and 31 December 2017 failed to meet the planned enrolment targets, according to GlobalData, a leading data and analytics company. The company identified and analyzed enrollment efficiencies of 324 clinical trials during the period and found that on...

    Press Release Healthcare

    Need for supportive care in oncology will increase during the next decade

    The need for effective supportive care in oncology will increase in the next decade as patients continue to live longer and cancer progresses to become more like a chronic disease. This includes the need for chemotherapy-related conditions, as chemotherapy will remain the backbone of cancer therapy for the foreseeable future, observes GlobalData, a leading data and analytics company.

    Press Release Healthcare

    World Cancer Day: What will 2018 mean for cancer research and treatment?

    The theme of this year’s World Cancer Day held on 4th February of “We can. I can.” aimed to reinforce the public message that all individuals and groups can play their part in reducing the global burden of cancer. Indeed in recent years many events have involved collaborations between traditional drug developers, cancer treatment professionals and those of varying disciplines. Examples include the IBM Watson supercomputer which is helping physicians make treatment decisions and the development of other databases such as ASCO’s CancerLinQ which assists oncologists in monitoring and analyzing patient data.

    Press Release Healthcare

    Melanoma sales are projected to rise to $5.5bn in 2026

    The value of the melanoma market was estimated to be $3.3bn across the seven major markets (7MM*) in 2016. This is expected to grow to $5.5bn in 2026, at a Compound Annual Growth Rate (CAGR) of 5.3%, according to GlobalData, a leading data and analytics company.

Media Enquiries

If you are a member of the press or media and require any further information, please get in touch, as we’re very happy to help.

Emailpr@globaldata.com
PhoneEMEA: +44 207 832 4399
PhoneAPAC: +91 40 6616 6809
Onlinecontact online

56% of #consumers are concerned about the impact of diet. Join us for more insight @incosmetics #cosmetics #trends… https://t.co/wJOJOqYIJF